Stony Brook University Hospital pioneers catheter-free bladder monitoring with Bright Uro's wireless Glean system, designed to improve comfort and diagnostic accuracy.

Phase 1: Patients with positive uptake of 68Ga-FAP- 2286 will receive a fixed dose of 177Lu-FAP-2286 IV administered every 6 weeks for a maximum of 6 doses. Doses range between 3.7 and 9.25 GBq ...